Search research articles
Contact Us
Filters
Showing results (101-110 of 194) with videos related to
Page
of 20
Sort By:
Journal of Hepatology
|
February 22, 2011
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease
Eric Trépo, Thierry Gustot, Delphine Degré, et al.
Journal of Hepatology
|
June 20, 2014
Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program
Massimo Colombo, Simone Strasser, Christophe Moreno, et al.
Plos One
|
July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Journal of Hepatology
|
January 18, 2015
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4
Christophe Moreno, Christophe Hezode, Patrick Marcellin, et al.
Gastro Hep Advances
|
February 25, 2025
Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations
Alia Hadefi, Morgane Leprovots, Gilles Dinsart, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2017
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen
Stefan Bourgeois, Yves Horsmans, Frederik Nevens, et al.
Journal of Hepatology
|
April 6, 2013
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease
Eric Trépo, Romy Ouziel, Pierre Pradat, et al.
Plos One
|
September 24, 2015
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis
Antonia Lepida, Massimo Colombo, Inmaculada Fernandez, et al.
Hepatology (Baltimore, Md.)
|
July 1, 2025
Antibody response to microbiota antigens is associated with alcohol-related liver disease severity and predicts mortality
Antonella Putignano, Natasha S Kelkar, Dalila Lakhloufi, et al.
Hepatology (Baltimore, Md.)
|
June 4, 2013
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity
Anne Lemaire, Eric Trépo, Romy Ouziel, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 194) with videos related to
Sort By:
Page
of 20
Journal of Hepatology
|
February 22, 2011
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease
Eric Trépo, Thierry Gustot, Delphine Degré, et al.
Journal of Hepatology
|
June 20, 2014
Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program
Massimo Colombo, Simone Strasser, Christophe Moreno, et al.
Plos One
|
July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Journal of Hepatology
|
January 18, 2015
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4
Christophe Moreno, Christophe Hezode, Patrick Marcellin, et al.
Gastro Hep Advances
|
February 25, 2025
Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations
Alia Hadefi, Morgane Leprovots, Gilles Dinsart, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2017
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen
Stefan Bourgeois, Yves Horsmans, Frederik Nevens, et al.
Journal of Hepatology
|
April 6, 2013
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease
Eric Trépo, Romy Ouziel, Pierre Pradat, et al.
Plos One
|
September 24, 2015
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis
Antonia Lepida, Massimo Colombo, Inmaculada Fernandez, et al.
Hepatology (Baltimore, Md.)
|
July 1, 2025
Antibody response to microbiota antigens is associated with alcohol-related liver disease severity and predicts mortality
Antonella Putignano, Natasha S Kelkar, Dalila Lakhloufi, et al.
Hepatology (Baltimore, Md.)
|
June 4, 2013
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity
Anne Lemaire, Eric Trépo, Romy Ouziel, et al.
Page
of 20